BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Not yet recruiting · NCT07027423 · Registry updated 2025-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Not yet recruiting | Phase 1 | 2025-12-01 | NCT07027423 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Health Network, Toronto | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UHN- Princess Margaret Cancer Center | Toronto | Canada | 3 |